Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer
Clinical Colorectal Cancer · 2020-12 · 19 (4) · 256-262.e2
DOI: 10.1016/j.clcc.2020.06.009 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Clinical Colorectal Cancer, 2020-12. Verfasst von Federica Tosi und 28 weiteren Autor:innen. Beteiligte Einrichtung: Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Dipartimento di Oncologia ed Emato-Oncologia, Università degli Studi di…. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Pfizer, Fondazione Regionale per la Ricerca Biomedica.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Dipartimento di Oncologia ed Emato-Oncologia, Università degli Studi di Milano, Milan, Italy.
- Oncologia Medica 1, Istituto Oncologico Veneto - IRCCS, Padova, Italy.
- Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
- Department of Oncology, ASL BI, Ospedale degli Infermi, Biella, Italy; Istituto di Candiolo, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy.
- Istituto di Candiolo, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy.
- Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- Pfizer
- Fondazione Regionale per la Ricerca Biomedica
- European Society for Medical Oncology
- Bayer
- Horizon 2020
- Sanofi
- Fondazione Europea Ricerca Biomedica
Zitieren
APA
Tosi, F., Sartore-Bianchi, A., Lonardi, S., Amatu, A., Leone, F., Ghezzi, S., Martino, C., Bencardino, K., Bonazzina, E., Bergamo, F., Fenocchio, E., Martinelli, E., Troiani, T., Siravegna, G., Mauri, G., Torri, V., Marrapese, G., Valtorta, E., Cassingena, A., …, & Siena, S. (2020). Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer. Clinical Colorectal Cancer, 19(4), 256-262.e2. https://doi.org/10.1016/j.clcc.2020.06.009
Vancouver
Tosi F, Sartore-Bianchi A, Lonardi S, Amatu A, Leone F, Ghezzi S, et al. Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 2020;19(4):256-262.e2. doi:10.1016/j.clcc.2020.06.009
BibTeX
@article{Tosi2020,
author = {Tosi, Federica and Sartore-Bianchi, Andrea and Lonardi, Sara and Amatu, Alessio and Leone, Francesco and Ghezzi, Silvia and Martino, Cosimo and Bencardino, Katia and Bonazzina, Erica and Bergamo, Francesca and Fenocchio, Elisabetta and Martinelli, Erika and Troiani, Teresa and Siravegna, Giulia and Mauri, Gianluca and Torri, Valter and Marrapese, Giovanna and Valtorta, Emanuele and Cassingena, Andrea and Cappello, Giovanni and Bonoldi, Emanuela and Vanzulli, Angelo and Regge, Daniele and Ciardiello, Fortunato and Zagonel, Vittorina and Bardelli, Alberto and Trusolino, Livio and Marsoni, Silvia and Siena, Salvatore},
title = {Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer},
journal = {Clinical Colorectal Cancer},
year = {2020},
volume = {19},
number = {4},
pages = {256--262.e2},
doi = {10.1016/j.clcc.2020.06.009}
}
EUVIMED